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Abstract
Background & Aims: Hepatitis B virus (HBV) infection carries substantial stigma in China. We surveyed HBV knowledge and
stigma among chronic hepatitis B (CHB) patients and persons without HBV infection in Beijing, China. Methods: Four hun-
dred and thirty five CHB patients and 801 controls at Peking University People’s Hospital were surveyed. Results: Chronic
hepatitis B patients were older (mean 46 vs. 39 years) and more often men (71 vs. 48%) than controls. Mean knowledge
score was 11.9/15 for CHB and 9.3/15 for control patients (P < 0.001). Average stigma score was 22.1/39 for CHB and
19.2/30 for control patients. Controls expressed discomfort with close contact (45%) or sharing meals with CHB patients
(39%) and believed CHB patients should not be allowed to work in restaurants (58%) or childcare (44%). Chronic hepatitis
B patients felt that they were undesirable as spouses (33 vs. 17%) and brought trouble to their families (58 vs. 34%) more
often than controls. Despite legal prohibitions, 40% of CHB patients were required to undergo pre-employment HBV test-
ing, and 29% of these individuals thought that they lost job opportunities because of their disease status. 16% of CHB
patients regretted disclosing their HBV status and disclosure was inversely associated with stigma. Higher stigma was associ-
ated with older age, lower education and lower knowledge score among controls; and with lower education, younger age,
having undergone pre-employment HBV testing and regret disclosing their HBV status among CHB patients. Conclusion:
Despite high prevalence of CHB in China, our study shows knowledge is limited and there is significant societal and internal-
ized stigma associated with HBV infection.
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The prevalence of chronic hepatitis B virus (HBV)
infection is disproportionately high in China, with
recent estimates of almost 75 million HBV carriers,
affecting 5.49% of China’s population of 1.36 billion
people (1–3). The financial costs related to its preven-
tion, care, and research amount to an estimated $110
billion in government investment per year, but the
social burden is often overlooked (4, 5). Despite
recent national laws prohibiting discrimination
towards HBV carriers from employers and schools
and additional regulations put forth in February 2010,
acts of discrimination are still commonly reported
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(6–8). A recent study of 1607 postings from a major
online chronic hepatitis B (CHB) support group (The
Hepatitis B Camp Network of China) reported
numerous anecdotes of institutional discrimination,
relationship difficulties, limited health care access and
financial constraints (9). Stigma for CHB patients
remains a national problem in China.
Health-related stigma is a social process characterized
by the devaluation of a person on the basis of disease or
health identity (10, 11). Research into health-related
stigma has been dominated by studies on HIV/AIDS,
leprosy and mental illness, with few examining stigma
associated with CHB (12). A 2012 study of 343 subjects
enrolled from a general practice clinic and an English as
a second language class at a Chinese community center
in Toronto showed stigma was common, and low
stigma and high knowledge scores were independent
predictors of prior HBV screening (13). Another study
of 201 Chinese patients seen in an internal medicine
clinic in Chicago’s Chinatown found stigma was greatest
in the fear of contagion domain and that familiarity
with HBV was inversely related to stigma (14). Although
both studies included mostly Chinese immigrants, their
findings may not reflect stigma associated with HBV in
mainland China. Indeed, a study conducted on 6538
adults in rural communities in China in 2015 found a
high level of discrimination against CHB patients: fear
of transmission of infection and low level of education
were major contributors to discrimination (15). None
of these studies compared the perspectives of infected
persons and uninfected controls.
Our study seeks to build on the literature by assessing
levels of HBV knowledge and stigma in CHB patients
and uninfected controls living in China. By offering a
detailed survey of transmission routes and stigma
domains from the perspective of both the stigmatized
and that of their community, we aimed to identify areas
for improvement that will reduce stigma, both real and
perceived, faced by CHB patients.
Methods
Study design
We conducted a survey study of CHB patients and con-
trols attending outpatient clinics at the People’s Hospi-
tal, Peking University Health Science Center (PUHSC)
in Beijing, China between June 8 and July 21, 2015. The
Peking University People’s Hospital is a large tertiary
care hospital with 2.8 million outpatient visits in 2015,
of which 90 000 were visits to the hepatology clinic.
Chronic hepatitis B patients were enrolled from the hep-
atology clinic and control patients with no known diag-
nosis of HBV were enrolled from a health check-up
clinic and a gastroenterology clinic. The surveys were
completed by patients or administered verbally to
patients who were unable to read the surveys by one of
three medical students from the University of Michigan.
This study was conducted as a global health project
by medical students from the University of Michigan in
collaboration with the Peking University People’s
Hospital. The supervising faculty from both teams had
been collaborating on similar student projects as well as
other research projects since 2011. The three medical
students were selected based on their fluency in Man-
darin Chinese and underwent training in human sub-
jects research and survey implementation at the
University of Michigan followed by orientation at the
hepatology clinic at the Peking University People’s
Hospital. The students were instructed to read the ques-
tions and options for responses verbatim and not to
interpret the questions or influence the responses when
administering the surveys. We obtained approval from
the Institutional Review Board of the University of
Michigan and the Institutional Review Board of Peking
University for this study. All participation was voluntary
and patients provided verbal consent.
Survey
The survey included demographic information and
questions concerning knowledge about HBV, and
stigma and discrimination related to HBV. The stigma
and knowledge questions were adapted from studies by
Li et al. in Canada and Cotler et al. in the United States
(13, 14). Separate surveys with corresponding questions
were administered to the CHB and control groups. The
surveys were initially developed in English, translated
into Chinese and then back-translated to verify accuracy
in translation. We conducted pilot testing on seven
CHB and 13 control patients at PUHSC and revisions
were made based on feedback from these patients. A
copy of the surveys is included in the supplementary
material.
HBV Knowledge
The knowledge component of the survey consists of
15 yes/no/don’t know questions with eight questions
Key points
 Our study compared chronic hepatitis B (CHB)
patients and non-infected controls knowledge and
stigma about hepatitis B in China.
 We found stigma in all four domains: interper-
sonal relationship, physical contact, employment and
perception; with average stigma score of 22.1/39 for
CHB and 19.2/30 for control patients.
 Higher stigma was associated with older age, lower
education and lower knowledge score among con-
trols; and with lower education, younger age, having
undergone pre-employment HBV testing, and regret
disclosing their HBV status among CHB patients.
 Chronic hepatitis B patients in China blame them-
selves for being a burden to their family and face
employment-based discrimination.
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on modes of transmission of HBV and seven ques-
tions on the progression of HBV and disease man-
agement. A correct answer was given one point and
an incorrect/do not know response was given zero
points.
HBV stigma
The stigma section included 13 questions for CHB
patients and 10 questions for control patients. The ques-
tions were organized across four domains: interpersonal
relationships, personal contact, employment and per-
ception. Seven questions probing the same issues were
administered to both CHB and control patients with
parallel phrasing to assess how CHB patients perceived
themselves and how uninfected persons perceived HBV
carriers. For each statement, patients indicated whether
they agreed, disagreed or were neutral. A response indi-
cating a high degree of stigma was given three points, a
neutral response was given two points, and a response
indicating no stigma was given one point. The maxi-
mum stigma score was 39 points for CHB patients and
30 points for control patients with higher scores indicat-
ing higher degree of stigma. Chronic hepatitis B patients
were also asked if they disclosed their HBV status to
others, whether they regretted doing so, whether they
had been required to undergo HBV testing prior to
employment and whether they had been fired because of
their HBV status.
Data analyses
Data were analysed with the IBM SPSS Statistics (SPSS)
version 23 (Armonk, NY, USA). Comparisons between
groups were conducted using t-tests for continuous data
and chi-squared tests for categorical data. Multiple lin-
ear regression analysis was performed to determine the
factors that predict HBV knowledge and stigma.
Results
A total of 435 CHB and 801 control patients (365
from the health check-up clinic and 436 from the
gastroenterology clinic) were enrolled in the study. Of
the CHB patients approached for this study, 77%
participated and there were no differences in demo-
graphics between those who did and those who did
not participate in the study. The demographic charac-
teristics of the patients are summarized in Table 1.
Chronic hepatitis B patients were older, more likely
male, and had less education than control patients.
Among control patients, those recruited from the gas-
troenterology clinic were older, more likely female,
and had less education than those at the health
check-up clinic. Control patients enrolled at the gas-
troenterology clinic were more similar to CHB
patients in terms of age and education level, though
they were still more likely to be female. The majority
(69%) of CHB patients had been diagnosed more
than 10 years ago while 16% had been diagnosed
within the last 5 years. Three-quarters of CHB
patients were receiving HBV treatment. Roughly half
(54%) of CHB and 11% of control patients had fam-
ily members diagnosed with HBV. In the control
group, 52% had been tested for HBV and 60% had
been vaccinated.
The majority of the surveys were self-administered by
patients (79% of CHB and 80% of controls). In both
groups, subjects who self-administered the survey were
significantly younger (mean age 42.4 vs. 60.4 years for
CHB, P < 0.001; and 35.9 vs. 52.5 years for controls,
P < 0.001), and more likely to have university education
than those who had surveys verbally administered by a
researcher (56 vs. 24% of CHB, P < 0.001; and 68 vs.
41% of controls, P < 0.001). While there was no signifi-
cant difference in mean total knowledge score (11.9 vs.
11.8 for CHB and 9.4 vs. 9.2 for controls), mean stigma
score was higher in patients who self-administered the









Age, Mean  SD*† 46.2  15.5 39.2  17.6 26.3  7.7 49.9  16.4
Gender (%)*†
Male 71 48 56 40
Female 29 52 44 60
Education (%)*†
High school or less 51 37 24 48
College or postgraduate 49 63 76 52
Marital status (%)*†
Single 12 42 78 13
Married 82 54 19 82
Other 6 4 3 5
Family members with CHB (%)* 54 11 9 14
*P < 0.001 between CHB and control.
†P < 0.001 between controls enrolled in health check-up and gastroenterology clinics.
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surveys than those who had the surveys administered by
a researcher (22.4 vs. 21.0 for CHB, P = 0.023; and 20.3
vs. 18.9 for controls, P < 0.001).
HBV Knowledge
Knowledge scores (maximum 15) were significantly
higher for CHB patients than controls. The average total
knowledge score was 11.9  2.3 for CHB patients and
9.3  2.9 for controls (P < 0.001). The average trans-
mission knowledge score (maximum 8) was 5.8  1.6
for CHB patients and 4.4  1.8 for controls
(P < 0.001) while the average outcome and disease
management knowledge score (maximum 7) was
6.0  1.2 for CHB patients and 4.9  1.7 for controls
(P < 0.001). Having a family member with HBV was
significantly associated with a higher total knowledge
score and higher transmission knowledge score for the
control group (P < 0.001 for both) but not the CHB
group.
Transmission
A higher percentage of CHB patients responded cor-
rectly to each question on HBV transmission than con-
trols (Fig. 1). Although most CHB and control patients
correctly recognized HBV can be transmitted from
mother-to-child (85% CHB vs. 72% controls,
P < 0.001), roughly half of CHB patients and controls
also thought HBV is an inherited disease (57% CHB vs.
52% controls, P = 0.028). Most (71%) CHB patients,
but only 47% controls, knew HBV can be transmitted
sexually (P < 0.001). The biggest discrepancy in
knowledge between the two groups pertains to HBV
transmission via sharing food or utensils, with 70% of
CHB patients but only 27% of controls correctly identi-
fying that sharing food or utensils does not spread HBV
(P < 0.001).
Outcome and disease management
Chronic hepatitis B patients had significantly greater
knowledge regarding HBV progression than controls. A
higher percentage of CHB patients compared to control
patients recognized that HBV can progress to cirrhosis
(78% CHB vs. 67% controls, P < 0.001), liver cancer
(91% CHB vs. 59% controls, P < 0.001), and lifelong
infection (75% CHB vs. 55% controls, P < 0.001). Addi-
tionally, a higher percentage of CHB patients than con-
trols knew that HBV can be treated with medications
(91% CHB vs. 79% controls, P < 0.001) and prevented
by vaccination (92% CHB vs. 86% controls, P < 0.001).
Sources of knowledge
The vast majority of CHB patients, regardless of age,
regarded their liver doctor as the most important source
of information on HBV. Almost a quarter of younger
CHB patients (age <55) stated the Internet was their
most important source of information compared to
only 4% of older CHB patients. In the control group,
television and public advertisements were the most
important source of information on HBV across all age
groups. Other sources of information included family or
friends and self-reading for older controls, and the
Internet for younger controls.
Fig. 1. Knowledge about modes of transmission of HBV. Subjects were asked to identify valid and invalid modes of transmission of HBV by
responding ‘true/false/don’t know.’ Valid modes of transmission are denoted by an asterisk. The figure depicts the % of correct responses to
each question within the CHB and control groups. For each transmission question, a significantly higher percentage of CHB patients
responded correctly compared to controls. Significance values are listed from left to right: P < 0.001, P < 0.001, P < 0.001, P = 0.023,
P < 0.001, P < 0.001, P = 0.028, P < 0.001.
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Multiple linear regression analysis
Multiple regression analyses to predict total knowledge
and transmission knowledge scores were performed
using age, gender and education. Higher education,
older age and female gender predicted higher total
knowledge score for controls (P < 0.001, P < 0.001,
P = 0.014, respectively) but only higher education was a
significant predictor for the CHB group (P < 0.001).
For transmission knowledge score, only higher educa-
tion was a significant predictor of higher scores for both
control (P < 0.001) and CHB groups (P < 0.001).
HBV stigma
The average stigma score for CHB patients was
22.1  5.2 (maximum 39) and for controls 19.2  3.8
(maximum 30). Among controls, having a family mem-
ber with CHB or having been tested for HBV or vacci-
nated against HBV did not significantly impact stigma
scores. Responses to each item are shown in Table 2 and
responses to the seven items common to both CHB
patients and controls are shown in Figure 2.
Interpersonal relationship domain
In the interpersonal relationship domain, CHB patients
responded with higher levels of stigma than controls.
More than half (58%) of CHB patients feel they have
brought trouble to their families and 33% feel they
would not be desirable as spouses. In contrast, fewer
controls believe CHB patients bring trouble to families
(34%) or are less desirable spouses (17%). These strong
responses stand in contrast with the actual discrimina-
tion felt by CHB patients: only 5% reported discrimina-
tion from their families and only 13% from their
friends.
Physical contact domain
In the physical contact domain, controls responded
with higher levels of stigma: 45% indicated HBV car-
riers should avoid close contact with others and 39%
indicated HBV carriers should avoid sharing meals
with others compared to 36 and 20% of CHB
patients respectively. Both CHB patients and controls
who thought HBV can be spread by sharing food and
eating utensils were more likely to indicate CHB
patients should avoid sharing food with others (37
vs. 15% of CHB, P < 0.001; 50 vs. 15% of controls,
P < 0.001) (Table 3).
Employment domain
In the employment domain, only 11% of controls
responded that HBV carriers were not desirable as
employees yet 58% felt HBV carriers should not be
allowed to work in restaurants and 44% felt they should
not be allowed to work with children. Among CHB
patients, 40% reported having to undergo pre-employ-
ment HBV screening, 19% felt discriminated by
coworkers or employers and 15% reported having lost
job opportunities because of their HBV status. Chronic
hepatitis B patients who had to undergo pre-employ-
ment HBV screening were more likely to report being
Table 2. Responses of CHB patients and controls to questions on stigma
CHB, n = 435 Control, n = 801
Agree Neutral Disagree Agree Neutral Disagree
Domain 1. Interpersonal relationships
Bring trouble to family 58 21 21 34 31 35
Not as desirable as a spouse 33 20 47 17 39 44
Should not be isolated by friends/ family 71 12 17 n/a n/a n/a
Discriminated by family 5 12 83 n/a n/a n/a
Discriminated by friends 13 28 59 n/a n/a n/a
Domain 2. Physical contact
Should avoid close contact with others 36 22 42 45 25 30
Should avoid sharing meals with others 20 20 60 39 27 34
Domain 3. Employment
Discriminated by coworkers 19 30 51 n/a n/a n/a
Discriminated by employers 19 33 48 n/a n/a n/a
Been denied jobs/fired from jobs 15 19 66 n/a n/a n/a
Should be allowed to work in restaurants n/a n/a n/a 20 22 58
Should be allowed to work with children n/a n/a n/a 26 30 44
Not as desirable as an employee n/a n/a n/a 11 30 59
Domain 4. Perception
Should be blamed for having HBV 17 30 53 3 10 87
Can be trusted not to bring harm to others 72 20 8 54 32 14
Put others at risk for HBV 52 18 30 57 30 13
Results expressed as percent of CHB patients or controls.
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denied employment (29 vs. 6%, P < 0.001) compared
to those not required to undergo testing (Table 3).
Perception domain
Responses in the perception domain were mixed, 17%
of CHB patients believed they should be blamed for
having HBV and 72% felt they could be trusted not to
bring harm to others. In contrast, only 3% of controls
felt HBV carriers should be blamed for having HBV and
54% felt HBV carriers could be trusted not to bring
harm to others.
Multiple linear regression analysis
Multiple regression analyses to predict stigma score in
the control group were performed using education,
age, gender and total knowledge score. Lower educa-
tion, older age and lower total knowledge score were
significant predictors of higher stigma score (Table 4).
Analysis in the CHB group included two additional
factors: requirement of pre-employment testing and
regret of disclosure of HBV status. Lower education,
younger age, being required to undergo pre-employ-
ment testing and regret towards disclosure of HBV
status were significant predictors of higher stigma
score. Similar findings were observed when total
knowledge score was replaced by transmission knowl-
edge score; and transmission knowledge score was a
stronger predictor of stigma than total knowledge
score in the control group (Table 4).
Disclosure of HBV status
Most CHB patients indicated that they disclosed their
HBV status to their spouse/significant other (88%), par-
ents (80%) and siblings (81%) but fewer disclosed their
status to their children (57%), close friends (47%),
coworkers (31%), employers (26%) or doctors/dentists
(49%). Chronic hepatitis B patients who agreed with the
statement ‘CHB patients bring trouble to their family’
were less likely to disclose their HBV status to their sig-
nificant others or children (Table 3). Overall, 16% of
CHB patients regretted disclosing their status to others.
Discussion
In this study of 435 CHB patients and 801 controls con-
ducted in Beijing, China, we found a high degree of per-
ceived and self-imposed stigma among CHB patients.
We also identified a high degree of stigma towards CHB
patients from uninfected persons. Our data demonstrate
that HBV-related stigma affects multiple aspects of a
patient’s life, including interpersonal relationships,
physical contact, employment opportunities and per-
ception.
Stigma towards an infectious disease may be a result
of ignorance, especially in regards to routes of transmis-
sion. While a study of Chinese immigrants in Chicago
found that better knowledge about HBV transmission
was associated with lower stigma, a survey of a rural
population in China found no association between
knowledge of HBV transmission and discrimination
(14, 15). Our study found lower total knowledge score
Fig. 2. Response of CHB patients and controls to overlapping questions on stigma. Both CHB and control patients were asked to respond
‘agree/neutral/disagree’ to these seven statements used to assess stigma.
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in controls was significantly associated with higher
stigma and lower transmission knowledge score was an
even stronger predictor of stigma. In CHB patients, nei-
ther total knowledge nor transmission-based knowledge
correlated with stigma score but this may be related to
high knowledge score in this group. In accordance with
prior studies, there is a common misconception that
HBV can be spread by sharing food or eating utensils
(14, 16). We found that those with this misconception
were more likely to believe CHB patients should avoid
sharing food with others and should be barred from
working in a restaurant. Our findings suggest that edu-
cation programs to improve understanding of HBV
transmission in the general public may decrease stigma
towards HBV carriers.
Similar to other studies on stigma, we found that
higher education level correlated with lower stigma in
both CHB patients and controls (14, 15, 17). Age had
contrasting effects on stigma in the control and CHB
groups; whereas older controls had higher stigma scores,
older CHB patients had lower stigma scores. Perhaps,
this is reflective of how those living with the disease for
a longer period have developed ways to cope with the
stigma over time. Surprisingly, and contrary with the
study by Cotler et al. (14), we found that having a fam-
ily member with CHB had no impact on stigma scores
in the controls.
Stigma can also arise from moral judgment. A study
conducted in Hong Kong demonstrated that diseases like
HIV, which are associated with perceived immoral action
related to injection drug use or sexual contact, had a
higher degree of stigma than diseases like tuberculosis or
SARS, which are transmitted through air droplets (18).
Vaughn-Sandler et al. (19) surveyed patients with cirrho-
sis and found that 82% felt stigmatized because of the
perceived association between cirrhosis and alcoholism.
In our study, the vast majority of our CHB patients and
controls knew HBV can be transmitted from infected
mothers to their infants, a mode of transmission less
associated with immorality, yet only half of the controls
realized HBV can be transmitted sexually. Thus, per-
ceived immoral action is unlikely to be a major contribu-
tor to stigma associated with HBV infection in China.
We found an alarmingly high degree of internalized
stigma among CHB patients. While Cotler et al. (14)
found that 36% of HBV carriers believed they bring
trouble to their families, that number was even higher
in our study, with 58% of CHB patients responding
along those lines. Furthermore, a third (both men and
women) felt their disease status made them less desir-
able as a spouse. The financial burden (e.g. cost of medi-
cal care and loss of job opportunities) and physical
impact (e.g. symptoms from HBV, risk of cirrhosis and
liver cancer and reduced life expectancy) may cultivate
guilt and lead patients to self-imposed blame. This trend
has previously been noted in mainland China. Kleinman
et al. documented instances of this behaviour in main-
land China in the context of HIV, and Wu et al., in a
study of Chinese Canadians with CHB in Toronto,
showed that 31% of CHB patients were ashamed of their
illness and recent immigrants were most likely to
express this sentiment (16, 20). Internalized stigma may
be unwarranted, as controls in our study were less likely
to indicate that CHB patients bring trouble to their fam-
ilies than CHB patients themselves. Our findings suggest
that healthcare workers should encourage open dialogue
between patients and families and educate patients on
how to manage their disease and prevent transmission.
Our study confirms reports that CHB patients in
China face barriers outside the home. The non-govern-
mental organization Beijing Yirenping Center provides
free legal assistance to HBV patients who have faced dis-
crimination. A survey by this group in 2007 found many
employers, including state-owned enterprises, are non-
compliant with Chinese law and pre-employment HBV
testing and employment discrimination remain wide-
spread (6, 9, 20). An updated report in 2012 suggests
almost half of CHB patients have suffered from employ-
ment related discrimination (21). In our study, 40% of
Table 3. Correlations between hepatitis B virus (HBV) knowledge,
stigma, and disclosure
Chronic hepatitis B Control


































Having to undergo HBV testing prior to employment
Being fired or lost
a job
29%e (50/172) n/a
Not having to undergo HBV testing prior to employment
Being fired or lost
a job
6%e (16/261) n/a
aP < 0.05, bcdeP < 0.001.
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CHB patients reported they were required to undergo
pre-employment testing for HBV and there was a signif-
icant correlation between requirement for pre-employ-
ment testing and being denied job opportunities. While
legal prohibition of employment discrimination towards
HBV patients in China is in place, enforcement remains
lax.
Many other studies involving HBV, hepatitis C and
HIV/AIDS have shown stigma negatively impacts healthy
behaviours such as screening, likelihood of disclosure,
prevention of transmission and adherence to medications
(13, 14, 22, 23). In our study, CHB patients who dis-
closed their status to their family had significantly lower
stigma scores, which perhaps reflects that patients who
experience lower stigma are more comfortable about dis-
closing their status (24). Chronic hepatitis B patients
were less likely to disclose their HBV status to acquain-
tances outside of their immediate family, with low rates
of disclosure even to physicians and dentists. To improve
health outcomes of CHB patients, combating stigma
needs to be a priority among health care workers.
Our study is unique in that it is the first systematic
study on HBV stigma in China that includes both
infected and non-infected persons, though some limita-
tions exist. As our study was confined to one hospital in
Beijing, it is possible stigma associated with HBV infec-
tion is worse elsewhere in China. Chronic hepatitis B
patients differed from controls in terms of demographic
profile and this limits our comparison of responses
between the two groups but not analysis of responses
within the groups. Most of our CHB patients had been
diagnosed more than 10 years ago, giving them ample
time to understand and cope with their disease and thus
the stigma they perceive may differ from that of more
recently diagnosed patients. The large majority of sur-
veys were self-administered by CHB patients and
controls but some required verbal administration by
researchers, which could have affected the stigma scores.
Finally, our survey was limited in scope and there may
be other areas of stigma that were not addressed.
In summary, we have shown that living with HBV in
China has consequences beyond the clinical course of
the disease. Employment discrimination continues
despite legal prohibition, and self-guilt of CHB patients
is alarmingly common. We also found a high degree of
stigma towards CHB patients among uninfected persons
and fear of transmission might be a major contributor
to the negative attitudes. By quantifying stigma in mul-
tiple dimensions in both the affected and unaffected
populations, our study provided insights into the degree
of stigma associated with HBV infection and potential
interventions to reduce this burden.
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Table 4. Regression analysis predicting stigma in CHB and control patients
CHB Control
Predictors B 95% CI P-value B 95% CI P-value
Higher education 1.40 (2.39, 0.40) 0.006 0.91 (1.47, 0.35) 0.002
Age (years) 0.05 (0.08, 0.02) 0.004 0.04 (0.02, 0.05) <0.001
Female gender 0.70 (0.32, 1.73) 0.178 0.22 (0.31, 0.74) 0.417
Total knowledge score 0.001 (0.20, 0.20) 0.991 0.10 (0.20, 0.01) 0.030
Pre-employment test 2.63 (1.67, 3.59) <0.001
Regret of disclosure 2.78 (‘1.50, 4.05) <0.001
R2 0.16 0.07
Higher education 1.48 (2.47, 0.49) 0.003 0.86 (1.42, 0.30) 0.003
Age (years) 0.05 (0.08, 0.01) 0.004 0.04 (0.02, 0.05) <0.001
Female gender 0.72 (0.31, 1.74) 0.171 0.20 (0.32, 0.73) 0.443
Transmission knowledge score 0.10 (0.19, 0.40) 0.489 0.23 (0.37, 0.09) 0.002
Pre-employment test 2.63 (1.67, 3.59) <0.001
Regret of disclosure 2.75 (1.48, 4.02) <0.001
R2 0.17 0.07
Multiple regression was conducted using the variables of education, age, gender and knowledge score to predict stigma score in controls. A similar
model with two additional predictors (having undergone pre-employment testing and expression of regret of disclosure) was created to predict
stigma score in CHB patients. The unstandardized B coefficient shows the effect of each predictor on the dependent variable of stigma.
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